25 -12 (74) 2024 - Ergashov B.B. - THE FREQUENCY OF CARDIAC ARRHYTHMIAS IN PATIENTS WITH VARIOUS TYPES OF ONCOLOGY

THE FREQUENCY OF CARDIAC ARRHYTHMIAS IN PATIENTS WITH VARIOUS TYPES OF ONCOLOGY

Ergashov B.B. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Arrhythmias are often detected in cancer patients receiving treatment. The proposed review examines rhythm disturbances by the type of tachyarrhythmias, most often found in cancer patients, as well as their features, characteristic directly for oncological diseases, and emphasizes the importance of ECG monitoring for early diagnosis, treatment and monitoring of this cohort of patients who are more susceptible to the development of proarrhythmia. Oncologists should be fully aware of possible cardiac arrhythmias, and close cooperation between cardiologists and oncologists will lead to better stratification of the risk of developing cardiovascular diseases, monitoring and treatment.

Keywords: tachyarrhythmia, oncology, chemotherapy, arrhythmogenic effect, supraventricular tachycardia, ventricular tachycardia, cardioncology, cardiotoxicity.

First page

131

Last page

139

For citation:Ergashov B.B. - THE FREQUENCY OF CARDIAC ARRHYTHMIAS IN PATIENTS WITH VARIOUS TYPES OF ONCOLOGY//New Day in Medicine 12(74)2024 131-139 https://https://newdayworldmedicine.com/en/new_day_medicine/12-74-2024

List of References

  1. Beheiry S., Al-Ahmad, A., Natale, A. (2021). Atrial fibrillation and flutter: Diagnosis and treatment. In A. Tsiperfal, L.K. Ottoboni, S. Beheiry, A.Al-Ahmad, A. Natale, P. Wang (Eds.), Cardiac arrhythmia management: A practical guide for nurses and allied professionals (pp. 85-100). Chichester, West Sussex, UK: Wiley-Blackwell.
  2. Chugh S.S., Blackshear J.L., Shen W.K., Hammill S.C., Gersh B.J. (2011). Epidemiology and natural history of atrial fibrillation: Clinical implications. //Journal of the American College of Cardiology, 2011;37:371-378.
  3. Ciriaco P., Mazzone P., Canneto B., Zannini P. (2010). Supraventricular arrhythmia following lung resection for non-small cell lung cancer and its treatment with amiodarone. //European Journal of Cardio-Thoracic Surgery, 2010;18:12-16.
  4. Epstein A.E., DiMarco J.P., Ellenbogen K.A., Estes N.A., 3rd, Freedman R.A., Gettes L.S., Yancy C.W. (2008). АСС/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2012 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. //Journal of the American College of Cardiology, 2008;51(21):el-e62.
  5. Falk R.H., Dubrey S.W. (2020). Amyloid heart disease. In M.A. Gertz S.V. Rajkumar (Eds.), Amyloidosis: Diagnosis and treatment (pp. 107-128). New York, NY: Humana Press. 2020;107-128.
  6. Fuster V., Ryden L.E., Asinger R.W., Cannom D.S., Crijns H .J., Frye R.L.,Torbicki. A. (2001). АСС/AHA/LSC guidelines for the management of patients with atrial fibrillation: Executive summary: A report of the American College of Cardiology/American Heart European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Circulation, 2001;104:2118-2150.
  7. Fuster V. Ryden L.E. Cannom D.S., Crijns H.J. Curtis A.B., Ellenbogen K.A., Wann L.S., (2021). 2021ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed In partnership with die European Society of Cardiology and In collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. //Journal of the American College of Cardiology, 2021;57:el01-el98.
  8. Go A.S., Hylek E.M., Phillips K.A., Chang Y., Henault L.E., Selby J.V., Singer D.E. (2011). Prevalence of diagnosed atrial fibrillation in adults:National implications for rhythm management and stroke prevention: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA, 2011;285:2370-2375.
  9. Granada J., Uribe W., Chyou P.H., Maassen K., Vierkant R., Smith P.N., Vidaillet H. (2010). Incidence and predictors of atrial flutter in the general population. //Journal of the American College of Cardiology, 2010;36:2242-2246.
  10. Hidalgo J.D., Krone R., Rich M.W., Blum K., Adkins D., Fan M.Y., Khoury H. (2014). Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: Incidence, risk factors and outcomes. //Bone Marrow Transplantation 2014;34:615-619.
  11. Hollings D.D., Higgins R.S.D., Faber L.P., Warren W.H., Liptay M.J., Basu S., Kim A.W. (2020). Age is a strong risk factor for atrial fibrillation after pulmonary lobectomy. //American Journal of Surgery, 2020;199:558-561.
  12. Ma J.-Y, Wang Y., Zhao Y.-E, Wu Z„ Liu L.-X., Kou Y.-L., Yang J.J. (2016). Atrial fibrillation after surgery for esophageal carcinoma: Clinical and prognostic significance. //World Journal of Gastroenterology 2016;12:449-452.
  13. Menard O., Martinet Y., Lamy P. (1991). Cisplatin-induced atrial fibrillation. //Journal of Clinical Oncology, 1991;9:192-193.
  14. Miller J.M., Zipes D.P. (2012). Therapy for cardiac arrhythmias. In R.O. Bonow, D.L. Mann, D.P. Zipes, P. Libby (Eds.), Braunwald’s heart disease: A textbook of cardiovascular medicine (2012; 9th ed., pp.771-823). Philadelphia, W.B. Saunders.
  15. Montella L., Caraglia M., Addeo R., Costanzo R., Faiola V., Abbruzzese A., Del Prete S. (2005). Atrial fibrillation following chemotherapy for stage IIIE diffuse large B-cell gastric lymphoma in a patient with myotonic dystrophy (Steinert’s disease). //Annals of Hematology, 2005;84:192-193.
  16. Murthy S.C., Law S. Whooley B.P., Alexandrou A., Chu K.-M., Wong J. (2003). Atrial fibrillation after esophagectomy is a marker for postoperative morbidity and mortality. //Journal of Thoracic and Cardiovascular Surgery, 2003;126:1162-1167.
  17. Olgin J., Zipes D.P. (2012). Therapy for cardiac arrhythmias. In R.O. Bonow, D.L. Mann, D.P.Zipes. P.I. Libby (Eds.), Braunwald’s heart disease: A textbook of cardiovascular medicine (2012;9th cd., 710-743). Philadelphia, W.B. Saunders.
  18. Olivieri A., Corvatta L., Montanari M., Brunori M., Offidani M., Ferretti G.F., Leoni P. (1998). Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells. //Bone Marrow Transplantation, 1998;21:1049-1053.
  19. Olshansky B., Rosenfeld L.E., Warner A.L., Solomon A.J., O’Neill G., Sharma A., Greene H.L. (2004). The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: Approaches to control rate in atrial fibrillation. //Journal of the American College of Cardiology 2004;43:1201-1208.
  20. Onaitis M., D’Amico T., Zhao Y., O’Brien S., Harpole D. (2010). Risk factors for atrial fibrillation after lung cancer surgery: Analysis of the Society of Thoracic Surgeons general thoracic surgery database. //Annals of Thoracic Surgery 2010;90:368-374.

    file

    download